Remaining authorization is estimated: we derive it from reported spend, or convert a share authorization at the latest close. Check the linked filings.
Programs
Authorized on
Authorized
Remaining
Expires
Terms
16-Nov-26
$5m
$5mEST
n/a
Stock repurchase program for up to $5 million of common stock following receipt of $20 million development milestone payment from Takeda8-K filed 16-Nov-26
08-Sep-26
$5m
$3m
28-Feb-27
On September 8, 2026, our board of directors authorized a stock repurchase program to repurchase up to $5.0 million of our common stock from time to time prior to February 28, 2027 (the “September 2026 Repurchase Program”).10-Q filed 05-Nov-26
Open-market repurchases
Repurchased per month, USD (≈ shares × average price)